John Brenkus: The Science of The Super Patch

John Brenkus: The Science of The Super Patch

John Brenkus is a co-founder of BASE Productions, he co-created the groundbreaking series Fight Science for the National Geographic Channel and serves as the on-air host, co-creator, and executive producer of ESPN’s six-time Emmy Award-winning show Sport Science. The future of wellness in a Patch. Wellness and performance mean different things to different people. At […]

John Brenkus: The Science of The Super Patch Read More »

Sublingual Semaglutide

A Needle-Free Approach to Effective Weight Loss In the ever-evolving landscape of medical advancements, a groundbreaking solution has emerged for individuals seeking effective weight loss strategies without the fear of needles. Sublingual Semaglutide, a revolutionary medication, offers an innovative approach to weight management. Designed for those who prefer a non-invasive method, this anhydrous liquid-based product

Sublingual Semaglutide Read More »

mounjaro vs wegovy

Mounjaro vs Wegovy

Pharmaceutical giant, Lilly, has launched a clinical trial that will compare the efficacy of their newly released drug, Mounjaro, with Novo Nordisk’s Wegovy in treating obesity. This head-to-head trial will evaluate the weight loss achieved by patients who take either Mounjaro or Wegovy over a period of 52 weeks. The trial will involve around 1,200

Mounjaro vs Wegovy Read More »

semaglutide for weight loss

Semaglutide For Weight Loss

Discovering the Benefits of Semaglutide for Sustainable Weight Loss Are you tired of trying various weight loss programs and seeing little to no results? It’s time to discover the benefits of Semaglutide. This new drug has been making waves in the weight loss industry due to its ability to sustainably promote weight loss. Unlike other

Semaglutide For Weight Loss Read More »

Tirzepatide Weight Loss

Tirzepatide is a new medication that has shown promising results for weight loss and glycemic control in clinical trials. It is a glucagon-like peptide-1 (GLP-1) receptor agonist that also activates the glucagon and glucose-dependent insulinotropic polypeptide (GIP) receptors. It is being developed by Eli Lilly and Company and is currently in phase 3 clinical trials.

Tirzepatide Weight Loss Read More »

Semaglutide Benefits

Semaglutide is a medication used in the treatment of obesity and type 2 diabetes mellitus. It belongs to the class of drugs known as GLP-1 receptor agonists, which act on the GLP-1 receptor in the pancreas to stimulate insulin secretion and reduce glucagon secretion. Semaglutide is similar to the naturally occurring hormone glucagon-like peptide-1 (GLP-1),

Semaglutide Benefits Read More »